In order to be a vaccine provider in philly, months long application process, hours of webinar (mid-day), upload vaxx administered, wasted, in stock to 2 different websites every 24 hours, unpredictable allocation from local DOH, 30 day expiration in a -4 fridge. 1/
After we vaxxed everyone who wanted vax in the practice, walked to almost every business <1mile, street cleaning crews, random passerby’s etc .. declining demand / reg. requirements made it 2 hard to maintain vax stock.
Federal allocation schemes that have wide popular support generally favor big players that can navigate regulatory thicket, grease the right wheels to get early disbursements of product, (and make a small killing doing it)
Alternative approach : allow direct purchase from manufacturers.. has problems, but not sure it’s worse when it comes down to end goal ( get vax out to as many arms as possible )

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Anish Koka

Anish Koka Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @anish_koka

11 Sep
Lots of great discussion about myocarditis and how its defined In a recent preprint from authors (pictured below)

medrxiv.org/content/10.110… Image
In this preprint , the VAERS database was interrogated for anyone given a diagnosis of myocarditis/pericarditis/myopericarditis/chest pain AND appears to require an abnormal very sensitive blood marker of cardiac damage (troponin) Image
A few bites about the VAERs database. It was legislated into existence via the National Childhood Vaccine Injury Act (NCVIA) in 1986, which was a mechanism to shield vax manufacturers from litigation related to potential adverse events after getting vaccinated
Read 27 tweets
6 Sep
Increasingly difficult to break through to many patients skeptical of recommendations seen coming from the medical establishment or through the mainstream media 🧵
Why is there a growing segment of the population that doesn’t believe experts/media ? Let’s start with a tragic non-med story of the last week.

Here’s the @AP account on a drone attack & what comes to light after someone actually investigates.

Everyone now knows about the fake ivermectin overdoses flooding ER story.

Journalists clearly know the headlines their audience will lap up — almost anything that will paint the half of the country that didn’t vote with them in a bad light will do
Read 10 tweets
19 Jun
Great 🧵 on recent neuro-COVID paper making the rounds.

1. Nothing in the paper speaks to the veracity of CSF/grey matter volumes derived by T1/T2. (This is most definitely not like measuring the size of the aorta over time)
2. Whatever measure they do derive overlaps w controls a lot when looking at the box/scatter plot. While we use criteria with this type of poor discrimination not infrequently, we would seldom make a therapeutic decision with a diagnostic test with this much overlap with normal
3. These findings are derived based on defining regions of interest (ROI) in the brain. Anyone that’s done this in the heart to define EF, or in MUGA studies knows how fraught that is.. so would want a core lab, multiple interpreters b4 calling a real difference ..
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(